Patients For Affordable Drugs Hiring Director of Communications and Media
Reporting to and collaborating with the Executive Director, the Director of Media and Communications leads P4AD’s national communications and media relations work.
Linda’s Story
I am Linda Richardson, from Port Charlotte, Florida, and I have had Multiple Sclerosis (MS) for the past 23 years, going on 24.
Report Update Reveals Drug Industry Funding And Control Of Groups Purporting To Represent Patients
Update To The Hidden Hand: Big Pharma’s Influence On “Patient Advocacy Groups” Shows Industry’s Control Of The Haystack Project, No Patient Left Behind, And The Community Oncology Alliance
New Reach Of Pharma’s Hidden Hand: Hiding In Plain Sight
Big Pharma's influence on patient advocacy groups
June 2023 Cancer Drug Prices Report
The BURDEN of Cancer Drug Prices On Patients. The RELIEF in the Inflation Reduction Act.
NEW REPORT: The Burden Of Cancer Drug Prices On Patients And The Relief The Inflation Reduction Act Provides
New Analysis Shows How The New Law Will Provide Average Savings of $7,590 To Some Cancer Patients With Medicare And Specifically To People Taking Seven High-Priced Cancer Drugs
STATEMENT: After Years Of Advocacy, Patients Will See Long-Awaited Relief From Eli Lilly’s Insulin Price Cut
“It’s Time For The Other Big Insulin Corporations To Follow Suit”
ICYMI: Q&A With P4AD’s Executive Director Merith Basey
Patient Advocate Lisa Ann Wetzel-Trainor Moderated A Conversation Where Merith Answered Questions On Her Background, The Inflation Reduction Act, And P4AD’s Future Goals:
